Esperion Therapeutics Cash from Investing (TTM) Insights

Esperion Therapeutics Inc (ESPR)

2.08 +0.02 (+0.97%) USD | NASDAQ | May 03, 16:00

2.08 0.00 (0.00%) After-Hours: 20:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2012. Upgrade now.

Date	Value
December 31, 2023	42.50M
September 30, 2023	30.71M
June 30, 2023	63.71M
March 31, 2023	51.21M
December 31, 2022	8.104M
September 30, 2022	-30.59M
June 30, 2022	-63.59M
March 31, 2022	-68.59M
December 31, 2021	-50.48M
September 30, 2021	-12.68M
June 30, 2021	-10.34M
March 31, 2021	-5.233M
December 31, 2020	21.36M
September 30, 2020	31.16M
June 30, 2020	23.52M
March 31, 2020	45.12M
December 31, 2019	64.23M
September 30, 2019	105.67M
June 30, 2019	151.01M
March 31, 2019	155.86M
December 31, 2018	140.45M
September 30, 2018	150.28M
June 30, 2018	-17.27M

Date	Value
March 31, 2018	-21.74M
December 31, 2017	-35.85M
September 30, 2017	-76.50M
June 30, 2017	64.09M
March 31, 2017	56.25M
December 31, 2016	10.12M
September 30, 2016	7.711M
June 30, 2016	-42.62M
March 31, 2016	-132.48M
December 31, 2015	-160.07M
September 30, 2015	-204.30M
June 30, 2015	-166.25M
March 31, 2015	-95.30M
December 31, 2014	-36.60M
September 30, 2014	-5.369M
June 30, 2014	-19.54M
March 31, 2014	-19.85M
December 31, 2013	-21.00M
September 30, 2013	-13.35M
June 30, 2013	0.0422M
March 31, 2013	0.0052M
December 31, 2012	-0.002M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-68.59M

Minimum

Mar 2022

151.01M

Maximum

Jun 2019

20.88M

Average

23.52M

Median

Jun 2020

Cash from Investing (TTM) Benchmarks